Literature DB >> 23242807

Donor-transmitted malignancy in a liver transplant recipient: a case report and review of literature.

Brian Kim1, Tinsay Woreta, Po-Hung Chen, Berkeley Limketkai, Andrew Singer, Nabil Dagher, Andrew Cameron, Ming-Tseh Lin, Ihab Kamel, Ahmet Gurakar.   

Abstract

Donor-transmitted malignancy is a rare complication of organ transplantation. This case illustrates a donor-transmitted adenocarcinoma in a patient 11 months after an orthotopic liver transplant for cryptogenic cirrhosis and hepatocellular carcinoma (HCC). Diagnosis of donor-transmitted malignancy may be challenging and can be confused with HCC recurrence. A timely diagnosis is crucial as a delay may limit treatment options. Biopsy of newly found liver lesions and the use of karyotypic and microsatellite analysis may be essential for diagnosis. Protocols should be in place to help recognize and limit the incidence of donor-transmitted malignancy.

Entities:  

Mesh:

Year:  2012        PMID: 23242807     DOI: 10.1007/s10620-012-2501-0

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  16 in total

Review 1.  An update on donor-derived disease transmission in organ transplantation.

Authors:  M G Ison; M A Nalesnik
Journal:  Am J Transplant       Date:  2011-03-28       Impact factor: 8.086

2.  Microsatellite analysis in post-transplantation lymphoproliferative disorder to determine donor/recipient origin.

Authors:  I O Ng; T W Shek; S N Thung; M M Ye; C M Lo; S T Fan; J M Lee; K W Chan; A N Cheung
Journal:  Mod Pathol       Date:  2000-11       Impact factor: 7.842

3.  Donor-transmitted malignancies in organ transplantation: assessment of clinical risk.

Authors:  M A Nalesnik; E S Woodle; J M Dimaio; B Vasudev; L W Teperman; S Covington; S Taranto; J P Gockerman; R Shapiro; V Sharma; L J Swinnen; A Yoshida; M G Ison
Journal:  Am J Transplant       Date:  2011-06       Impact factor: 8.086

4.  Origin of hepatocellular carcinoma recurring after allotransplantation revealed by microsatellite analysis.

Authors:  H Pfeiffer; C Ortmann; A Klein; B Brinkmann
Journal:  J Clin Pathol       Date:  1997-09       Impact factor: 3.411

5.  Risk for tumor and other disease transmission by transplantation: a population-based study of unrecognized malignancies and other diseases in organ donors.

Authors:  Sven Arvid Birkeland; Hans H Storm
Journal:  Transplantation       Date:  2002-11-27       Impact factor: 4.939

6.  A multiorgan donor cancer screening protocol: the Italian Emilia-Romagna region experience.

Authors:  Michelangelo Fiorentino; Antonia D'Errico; Barbara Corti; Silvia Casanova; Lorenza Ridolfi; Nicola Venturoli; Elena Sestigiani; Walter F Grigioni
Journal:  Transplantation       Date:  2003-12-27       Impact factor: 4.939

7.  Transplant tumor registry: donor related malignancies.

Authors:  H Myron Kauffman; Maureen A McBride; Wida S Cherikh; Pamela C Spain; William H Marks; Allan M Roza
Journal:  Transplantation       Date:  2002-08-15       Impact factor: 4.939

8.  Management of recipients of hepatic allografts harvested from donors with malignancy diagnosed shortly after transplantation.

Authors:  O Detry; P Honoré; N Jacquet; M Meurisse
Journal:  Clin Transplant       Date:  1998-12       Impact factor: 2.863

9.  Origin of adenocarcinoma in a transplanted liver determined by microsatellite analysis.

Authors:  Sanjay Kakar; Lawrence J Burgart; Michael R Charlton; Yuri Saito; Kevin Halling; Stephen N Thibodeau
Journal:  Hum Pathol       Date:  2002-04       Impact factor: 3.466

10.  Death from donor-transmitted malignancy despite emergency liver retransplantation.

Authors:  Gerald S Lipshutz; Lee Ann Baxter-Lowe; Tim Nguyen; Kirk D Jones; Nancy L Ascher; Sandy Feng
Journal:  Liver Transpl       Date:  2003-10       Impact factor: 5.799

View more
  3 in total

Review 1.  Donor transmitted and de novo cancer after liver transplantation.

Authors:  Rajeev Desai; James Neuberger
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

2.  Liver Transplantation From Donors With a History of Malignancy: A Single-Center Experience.

Authors:  Tamas Benkö; Dieter P Hoyer; Fuat H Saner; Jürgen W Treckmann; Andreas Paul; Sonia Radunz
Journal:  Transplant Direct       Date:  2017-10-18

3.  HERC5 is a prognostic biomarker for post-liver transplant recurrent human hepatocellular carcinoma.

Authors:  Feng Xue; Brandon W Higgs; Jiaqi Huang; Chris Morehouse; Wei Zhu; Xin Yao; Philip Brohawn; Zhan Xiao; Yinong Sebastian; Zheng Liu; Yun Xia; Dong Shen; Mike Kuziora; Zhengwei Dong; Hulin Han; Yi Gu; Jianren Gu; Qiang Xia; Yihong Yao
Journal:  J Transl Med       Date:  2015-12-11       Impact factor: 5.531

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.